Related Experiment Video
Updated: Jul 29, 2025

12:52
Electromechanical Assessment of Optogenetically Modulated Cardiomyocyte Activity
Published on: March 5, 2020
8.3K
Estimation of crossbridge-state during cardiomyocyte beating using second harmonic generation.
Hideaki Fujita1, Junichi Kaneshiro2, Maki Takeda3
1Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Life Science Alliance
|May 26, 2023
Summary
We developed a new assay to measure myosin crossbridge formation in heart cells, aiding cardiomyopathy research. This method helps assess drug efficacy and predict heart failure risk.
Area of Science:
- Cardiology
- Biophysics
- Cell Biology
Background:
- Understanding dynamic crossbridge formation in cardiomyocytes is vital for elucidating cardiomyopathy mechanisms and evaluating therapeutic interventions.
- Current methods may not fully capture the dynamic nature of actomyosin interactions in living cells.
Purpose of the Study:
- To establish a novel assay system for dynamically measuring second harmonic generation (SHG) anisotropy in pulsating cardiomyocytes.
- To correlate SHG anisotropy with myosin crossbridge status and assess actomyosin activity.
Main Methods:
- Developed an assay to dynamically measure SHG anisotropy from myosin filaments, reflecting crossbridge status in pulsating cardiomyocytes.
- Utilized inheritable mutations causing excessive myosin-actin interactions to validate the assay.
- Employed infrared two-photon excitation for intravital evaluation in a *Drosophila* disease model.
Main Results:
- Established a correlation between sarcomere length and SHG anisotropy, representing the crossbridge formation ratio during pulsation.
- Demonstrated that ultraviolet irradiation increases non-force-generating attached crossbridges during myocardial differentiation.
- Successfully evaluated myocardial dysfunction in a *Drosophila* model, showcasing the method's applicability.
Conclusions:
- The developed SHG anisotropy assay effectively evaluates actomyosin activity in cardiomyocytes, crucial for drug or genetic defect assessment.
- This method offers a valuable tool for risk assessment of future heart failure, complementing genomic inspection.

